{
  "paper_metadata": {
    "pmid": "33348885",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the production and purification of recombinant human transthyretin (hTTR) and mentions the wild-type (wt) and the highly amyloidogenic Y78F variant, but does not provide detailed penetrance data or individual patient information."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Tyr78Phe",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": "highly amyloidogenic variant"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The Y78F variant is described as highly amyloidogenic, with specific behavior in terms of protein modification and aggregation.",
        "assays": [
          "SDS-PAGE electrophoresis",
          "MALDI-TOF mass spectrometry",
          "fibrillogenesis assay"
        ]
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results and Discussion, paragraph 2",
      "additional_notes": "The paper focuses on the production and purification of TTR variants rather than clinical data.",
      "key_quotes": [
        "the highly amyloidogenic Y78F variant renders mainly the S-glutathionated form",
        "The amyloidogenic capacity is used as a quality parameter of the different protein batches."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Thr119Met",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": "protective mutation"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The T119M mutation is noted for its structural influence in stabilizing TTR.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results and Discussion, paragraph 2",
      "additional_notes": "The paper discusses the T119M mutation in the context of TTR stabilization.",
      "key_quotes": [
        "designed to mimic the structural influence of the protective T119M mutation"
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The paper primarily focuses on the production and purification of TTR variants without detailed clinical data."
  }
}